NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-285-2016-0-US-01 Glypican 2 As A Cancer Marker And Therapeutic Target US 62/253,000 Abandoned
NIAID E-152-2015-2-CA-02 Probiotic Therapeutic Applications CA National Stage 2967039 Abandoned
NIAID E-136-2013-0-US-05 Single-Domain VHH Antibodies Directed to NoroVirus Gi.1 and Gii.4 and Their Use US National Stage 14/889,774 10000556 Issued PDF
NCI E-261-2016-0-PCT-02 Compositions And Methods Of Diazeniumdiolate-based Prodrugs For Treating Cancer PCT PCT PCT/US2015/059428 Expired
NICHD E-209-2021-0-US-01 Kits And Methods To Distinguish False Labor And True Labor US 62/251,517 Abandoned
NHLBI E-034-2016-0-US-01 TSLP Induces Neutrophil Mediated Killing Of Methicillin-resistant Staphylococcus Aureus US 62/251,558 Abandoned
NICHD E-210-2021-0-US-01 Kits And Methods For Predictions And Treatment Of Preeclampsia US 62/251,589 Abandoned
NHLBI E-141-2009-0-US-03 APPARATUS AND METHOD FOR MAGNETIC RESONANCE IMAGING WITH HIGH SPATIAL TEMPORAL RESOLUTIONS US National Stage 14/889,135 10371779 Issued PDF
NHLBI E-166-2014-0-PCT-02 T Cells and Dendritic Cells for Polyomavirus Therapy PCT PCT PCT/US2015/059021 Expired
NIDDK E-038-2016-0-US-01 EXPRESSION OF IGF2BP1 FOR TREATMENT US 62/250,815 Abandoned
NIAID E-067-2016-0-US-01 A Novel Method Of Vaccination With An Attenuated RSV Vaccine Formulation US 62/251,030 Abandoned
NCI E-055-2017-0-US-01 Combing D2C7 Immunotoxin With Check Points Inhibitors US 62/250,749 Abandoned
NIAID E-131-2015-1-US-01 Neutralizing Antibodies to GP120 and Their Use US 62/250,378 Abandoned
NIAID E-133-2015-0-US-01 Neutralizing Antibodies to HIV-1 GP41 and Thier Use US 62/250,360 Abandoned
NIAMS E-073-2011-2-US-01 Antibodies the Bind to TL1A and Methods of Treating Inflammatory or Autoimmune Disease Comprising Administering Such Antibodies US CIP 14/931,149 9896511 Issued PDF
NCI E-097-2009-0-AU-10 Anti-human ROR1Antibodies AU DIV 2015252014 Issued
NCI E-035-2016-0-US-01 Methods of Producing T Cell Populations Using Prolyl Hydroxylase Domain-Containing Protein Inhibitors US 62/249,645 Abandoned
NCI E-263-2011-0-US-08 Psuedomonas Exotoxin A with Less Immunogenic B Cell Epitopes US DIV 14/927,645 9657066 Issued PDF
NCI E-187-2015-0-US-01 Compositions and Methods for the Treatment of HER2-Expressing Solid Tumors US 62/248,964 Abandoned
NCI E-108-2016-0-US-01 Targeted Cancer Therapy US 62/249,033 Abandoned
NCI E-109-2016-0-US-01 TARGETED CANCER THERAPY US 62/249,013 Abandoned
NIBIB E-247-2014-0-US-02 Systems and Method for Distinguishing Stimulated Emissions as a Means of Increasing the Signal of Fluorescence Microscopy US ORD 14/927,263 9791371 Issued PDF
NCI E-056-2011-0-US-18 The Development And Use Of A Recombinant Brachyury Saccharomyces Cerevisiae (yeast) Vaccine For The Prevention And/or Therapy Of Human Cancer US CON 14/926,372 9623097 Issued PDF
NIAID E-152-2015-1-US-01 Probiotic Therapeutic Applications US 62/247,494 Abandoned
NCI E-015-2013-0-US-03 Novel Peptide Hydrogels Generating Chemical Exchange Saturation Transfer MRI Contrast And Uses Thereof US National Stage 14/787,039 11235075 Issued PDF
NCI E-262-2005-0-ES-55 Mutated Pseudomonas Exotoxins with Reduced Antigenicity ES EP 15191388.6 Issued
NCI E-262-2005-0-PL-60 Mutated Pseudomonas Exotoxins with Reduced Antigenicity PL EP 15191388.6 Issued
NCI E-262-2005-0-CH-53 Mutated Pseudomonas Exotoxins with Reduced Antigenicity CH EP 15191388.6 Issued
NCI E-262-2005-0-GB-57 Mutated Pseudomonas Exotoxins with Reduced Antigenicity GB EP 15191388.6 Issued
NCI E-262-2005-0-IT-59 Mutated Pseudomonas Exotoxins with Reduced Antigenicity IT EP 15191388.6 Issued
NCI E-262-2005-0-IE-58 Mutated Pseudomonas Exotoxins with Reduced Antigenicity IE EP 15191388.6 Issued
NCI E-262-2005-0-DE-54 Mutated Pseudomonas Exotoxins with Reduced Antigenicity DE EP 15191388.6 Issued
NCI E-262-2005-0-FR-56 Mutated Pseudomonas Exotoxins with Reduced Antigenicity FR EP 15191388.6 Issued
NCI E-262-2005-0-FR-37 Mutated Pseudomonas Exotoxins with Reduced Antigenicity FR EP 15191395.1 Issued
NCI E-262-2005-0-DE-35 Mutated Pseudomonas Exotoxins with Reduced Antigenicity DE EP 15191395.1 Issued
NCI E-262-2005-0-IE-39 Mutated Pseudomonas Exotoxins with Reduced Antigenicity IE EP 15191395.1 Issued
NCI E-262-2005-0-IT-40 Mutated Pseudomonas Exotoxins with Reduced Antigenicity IT EP 15191395.1 Issued
NCI E-262-2005-0-ES-36 Mutated Pseudomonas Exotoxins with Reduced Antigenicity ES EP 15191395.1 Issued
NCI E-262-2005-0-PL-42 Mutated Pseudomonas Exotoxins with Reduced Antigenicity PL EP 15191395.1 Issued
NCI E-262-2005-0-NL-41 Mutated Pseudomonas Exotoxins with Reduced Antigenicity NL EP 15191395.1 Issued
NCI E-262-2005-0-BE-34 Mutated Pseudomonas Exotoxins with Reduced Antigenicity BE EP 15191395.1 Issued
NCI E-262-2005-0-AT-33 Mutated Pseudomonas Exotoxins with Reduced Antigenicity AT EP 15191395.1 Issued
NCI E-262-2005-0-GB-38 Mutated Pseudomonas Exotoxins with Reduced Antigenicity GB EP 15191395.1 Issued
NCI E-262-2005-0-GB-48 Mutated Pseudomonas Exotoxins with Reduced Antigenicity GB EP 15191391.0 Issued
NCI E-262-2005-0-BE-44 Mutated Pseudomonas Exotoxins with Reduced Antigenicity BE EP 15191391.0 Issued
NCI E-262-2005-0-AT-43 Mutated Pseudomonas Exotoxins with Reduced Antigenicity AT EP 15191391.0 Issued
NCI E-262-2005-0-ES-46 Mutated Pseudomonas Exotoxins with Reduced Antigenicity ES EP 15191391.0 Issued
NCI E-262-2005-0-PL-52 Mutated Pseudomonas Exotoxins with Reduced Antigenicity PL EP 15191391.0 Issued
NCI E-262-2005-0-FR-47 Mutated Pseudomonas Exotoxins with Reduced Antigenicity FR EP 15191391.0 Issued
NCI E-262-2005-0-DE-45 Mutated Pseudomonas Exotoxins with Reduced Antigenicity DE EP 15191391.0 Issued